Worth reading
25Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
17
Stores (total for 2 companies)Wording
Conditional
How definitive the wording is.This transaction
Share acquisition (addition to the group)CounterpartyIndividual shareholders (2 from 株式会社メディカメンテ and 1 from 株式会社MY; names not disclosed)
Disclosing companyQol Holdings Co.,Ltd.
TimelineThe spacing between the points is proportional to the actual number of days.
Target company
Operates 15 prescription pharmacies, Operates 2 prescription pharmacies
Location Sendai, Miyagi Prefecture, Sendai, Miyagi PrefectureShare capital ¥1 million, ¥1 millionDate of incorporation September 2013, March 2020
Procedures and assumptions
Management structure after acquisitionThe company stated that it will make maximum use of group resources, including exchanges among talented personnel and ICT. No specific details were provided regarding a change of corporate name, representative, or employee treatment.
| Item | Details |
|---|---|
| Transaction name | Share acquisition (addition to the group) |
| Counterparty name | Individual shareholders (2 from 株式会社メディカメンテ and 1 from 株式会社MY; names not disclosed) |
| Name of the Subject Company | 株式会社メディカメンテ, 株式会社MY |
| Business Description of the Subject Company | Operates 15 prescription pharmacies, Operates 2 prescription pharmacies |
| Location of the Subject Company | Sendai, Miyagi Prefecture, Sendai, Miyagi Prefecture |
| Capital Stock of the Subject Company | ¥1 million, ¥1 million |
| Date of Establishment of the Subject Company | September 2013, March 2020 |
| Date of board resolution | 30 September 2026 |
| Execution Date / Effective Date | 22 October 2026 (scheduled) |
| Management structure after acquisition | The company stated that it will make maximum use of group resources, including exchanges among talented personnel and ICT. No specific details were provided regarding a change of corporate name, representative, or employee treatment. |
Items this document does not state (22)
Net Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredVoting rights ownership percentageFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Impact on Business PerformanceContract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to Execution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To strengthen its contribution to community healthcare and home healthcare as a community-based family pharmacy. The company stated that it aims to expand its pharmacy business and enhance corporate value by promoting exchanges among talented personnel and making maximum use of group resources, including ICT.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.